Pharmaceutical Executive September 25, 2023
Mike Hollan

Cleve talks about the future of the industry and how data remains a key focus.

New technologies are changing the ways that life sciences and regulatory agencies approach the collection and analysis of data. Scott Cleve, vice president of regulatory operations, information, and compliance at Daiichi Sankyo sat down with Pharm Exec at the Veeva R&D and Quality Summit 2023 in Boston to discuss these topics.

Pharm Exec: What are the current struggles with the regulatory environment right now?

Scott Cleve: For regulatory, we are so focused with understanding the regulations for delivering our products to market and working with FDA. For us, that’s dictated by FDA requirements and guidance, which are more scientific in nature. Those change from time...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, FDA, Govt Agencies, Interview / Q&A, Pharma / Biotech, Trends
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article